Page 6 - Hal Barron News Today

The vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with an adjuvant.

A $1,530,000 grant from the Ralph C. Wilson, Jr. Foundation will help pay for the construction of the 6.5-mile Monroe Area Loop Trail.

There is a tendency, particularly in the healthcare and tech sectors, for companies to head to New York and other markets.

The deal to acquire the biotech firm is intended to strengthen GSK’s vaccine R&D and technology offering.

Affinivax is developing a vaccine to combat pneumococcal diseases which include pneumonia and meningitis as well as milder illnesses such as sinusitis.

British drugmaker GlaxoSmithKline on Tuesday snapped up US biopharmaceutical firm Affinivax for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm

GSK, which is gearing up to separate its consumer unit, has been under pressure to  to shore up its vaccine pipeline.

GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to acquire Affinivax, Inc. (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1 billion upfront payment and up to $1.2 billion in potential development milestones ...

LONDON, May 31 — British drugmaker GlaxoSmithKline today snapped up US biopharmaceutical firm Affinivax for up to US$3.3 billion (RM14 billion), expanding further into vaccines...

GSK will pay up to $3.3bn to acquire Affinivax, gaining access to its Multiple Antigen Presenting System (MAPS) technology and vaccine candidates.